Although available in wellness settings, AOD-9604 is not FDA-approved and should be used strictly in research contexts
In phase II and III studies, people who took cagrilintide along with semaglutide lost up to 15.7% of their body weight, compared to 5.1% who took a placebo
Done right, it will lead to proper reimbursement
E., Leff, T
Short-term (up to 4 weeks) : Brighter skin tone, better hydration, and increased energy levels Medium-term (13 months) : Reduced hyperpigmentation, more even skin tone, improved immunity, and sharper mental focus Long-term (over 3 months) : More pronounced skin brightening, anti-ageing effects, and liver health support To maintain these outcomes, patients are encouraged to: Stay hydrated by drinking 810 glasses of water daily Follow a diet rich in antioxidant-packed foods Use a broad-spectrum sunscreen (SPF 30+) every day While the improvements can be impressive, they are not permanent
The improving trajectory is crucial